157 related articles for article (PubMed ID: 21890445)
1. Socio-economic inequalities in testicular cancer survival within two clinical studies.
Nur U; Rachet B; Parmar MK; Sydes MR; Cooper N; Stenning S; Read G; Oliver T; Mason M; Coleman MP
Cancer Epidemiol; 2012 Apr; 36(2):217-21. PubMed ID: 21890445
[TBL] [Abstract][Full Text] [Related]
2. Clinical Disparities for Minorities and Foreign-Born Men With Undescended Versus Descended Testicular Germ Cell Tumors.
Klaassen Z; Reinstatler L; Wilson SN; Ellington C; Li Q; Terris MK; Moses KA
Clin Genitourin Cancer; 2016 Jun; 14(3):e251-5. PubMed ID: 26428610
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte and platelet counts as prognostic values of testicular germ cell tumours.
Herraiz-Raya L; Moreillo-Vicente L; Martínez-Ruiz J; Agustí-Martínez A; Fernández-Anguita PJ; Esper-Rueda JA; Salce-Marte L; Armas-Álvarez A; Díaz de Mera-Sánchez Migallón I; Martínez-Alfaro C; Giménez-Bachs JM; Donate-Moreno MJ; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2019; 43(6):284-292. PubMed ID: 31085041
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
5. Racial and socioeconomic disparities in retroperitoneal lymph node dissection and survival in nonseminomatous germ cell tumor: A population-based study.
Bhambhvani HP; Greenberg DR; Kasman AM; DeRouen MC; Cheng I; Eisenberg ML; Shah SA
Urol Oncol; 2021 Mar; 39(3):197.e1-197.e8. PubMed ID: 33423934
[TBL] [Abstract][Full Text] [Related]
6. Testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancer.
Schaffar R; Pant S; Bouchardy C; Schubert H; Rapiti E
BMC Urol; 2019 Jul; 19(1):64. PubMed ID: 31291913
[TBL] [Abstract][Full Text] [Related]
7. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
Cohn-Cedermark G; Stahl O; Tandstad T;
Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of nonseminomatous testicular germ cell tumors].
Nukui M; Nakao M; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maekawa M
Hinyokika Kiyo; 1991 Oct; 37(10):1281-5. PubMed ID: 1721771
[TBL] [Abstract][Full Text] [Related]
10. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Pedraza AM; Stephenson AJ
Curr Opin Urol; 2018 Sep; 28(5):448-453. PubMed ID: 29979237
[TBL] [Abstract][Full Text] [Related]
11. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
Lerro CC; Robbins AS; Fedewa SA; Ward EM
Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and survival of young Turkish patients with testicular germ cell tumors.
Ozgun A; Karagoz B; Tuncel T; Emirzeoglu L; Celik S; Bilgi O
Asian Pac J Cancer Prev; 2013; 14(11):6889-92. PubMed ID: 24377621
[TBL] [Abstract][Full Text] [Related]
13. [Management of localized germ-cell tumours of the testis].
Loriot Y; Fizazi K
Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for patients with stage I nonseminomatous testis cancer: it's all good.
Sagalowsky AI
Eur Urol; 2011 Apr; 59(4):563-5. PubMed ID: 21269757
[No Abstract] [Full Text] [Related]
16. A third option in the management of patients with clinical stage I nonseminomatous germ cell tumor?
Gressler VH; Levine LA; Vogelzang NJ
J Clin Oncol; 1990 Jan; 8(1):4-8. PubMed ID: 2153195
[No Abstract] [Full Text] [Related]
17. Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.
Lancet; 1985 Jan; 1(8419):8-11. PubMed ID: 2578205
[TBL] [Abstract][Full Text] [Related]
18. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
[TBL] [Abstract][Full Text] [Related]
19. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP
J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
